Literature DB >> 33084451

Lessons learned from clinical phenotypes in early psoriatic arthritis: the real-world Dutch south west Early Psoriatic ARthritis study.

F R Kasiem1, J J Luime1, M Vis1, M R Kok2, K Wervers1, A H Gerards3, Cwy Appels4, W L van der Graaff5, Mjf Starmans-Kool6, Ypm Goekoop-Ruiterman7, Jhlm van Groenendael8, L-A Korswagen3, J J Veris-van Dieren8, Jmw Hazes1, I Tchetverikov9.   

Abstract

Objective: This paper describes the baseline demographics, clinical characteristics, and patient-reported outcomes (PROs) according to clinical phenotype of patients with early psoriatic arthritis (PsA) for the purpose of creating a decision support system for daily clinical practice.Method: Patients with newly diagnosed PsA were included in the Dutch south west Early Psoriatic ARthritis (DEPAR) study. No classification criteria were applied, to ensure collection of real-world data on demographics, medication, clinical characteristics, and PROs. An IT infrastructure facilitated data collection.
Results: We described 527 patients, categorized according to the clinical phenotype stated by the rheumatologist at the time of diagnosis, namely monoarthritis (15%), oligoarthritis (40%), polyarthritis (23%), enthesitis (10%), axial disease (2%), and dactylitis (10%). Overall psoriasis severity was mild and 83 patients (16%) had no psoriasis. Short-term sick leave (> 1 day per 4 weeks) was 17% and long-term sick leave (> 4 weeks) was 4%. The group with phenotype enthesitis reported the longest duration of complaints, had the highest fatigue scores, and contained the highest percentage of patients with a Hospital Anxiety and Depression Scale (HADS) anxiety score ≥ 8 and depression score ≥ 8.
Conclusion: PsA patients presenting at outpatient clinics in the Netherlands had a mild degree of psoriasis, with impairment of quality of life and work productivity. Most patients presented with phenotype oligoarthritis. Those presenting with phenotype enthesitis more often reported scores suggestive of an anxiety or depression disorder and fatigue. It is important for attending rheumatologists to be aware of these differences when assessing patients with PsA.

Entities:  

Year:  2020        PMID: 33084451     DOI: 10.1080/03009742.2020.1803398

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  3 in total

1.  Management of particular clinical situations in psoriatic arthritis: an expert's recommendation document based on systematic literature review and extended Delphi process.

Authors:  Rosario García-Vicuña; Noemí Garrido; Susana Gómez; Beatriz Joven; Rubén Queiro; Julio Ramírez; Francisco Rebollo; Estíbaliz Loza; Agustí Sellas
Journal:  Rheumatol Int       Date:  2021-05-02       Impact factor: 3.580

2.  Sex-specific differences and how to handle them in early psoriatic arthritis.

Authors:  E Passia; M Vis; L C Coates; A Soni; I Tchetverikov; A H Gerards; M R Kok; P A J M Vos; L Korswagen; F Fodili; Y P M Goekoop-Ruiterman; J van der Kaap; M van Oosterhout; J J Luime
Journal:  Arthritis Res Ther       Date:  2022-01-11       Impact factor: 5.156

3.  The burden of psoriasis in patients with early psoriatic arthritis.

Authors:  Fazira R Kasiem; Marc R Kok; Jolanda J Luime; Ilja Tchetverikov; Kim Wervers; Lindy-Anne Korswagen; Nastasja H A M Denissen; Yvonne P M Goekoop-Ruiterman; Maikel van Oosterhout; Faouzia Fodili; Johanna M W Hazes; Marijn Vis
Journal:  Rheumatology (Oxford)       Date:  2022-04-11       Impact factor: 7.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.